Wilson Sonsini Goodrich & Rosati has advised Forte Biosciences. Paul Hastings LLP has advised Guggenheim Securities and Barclays. Forte Biosciences, Inc., a clinical-stage biopharmaceutical company specializing...
Forte Biosciences Announces $150 Million Public Offering of Common Stock
Esperto Medical’s Oversubscribed Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Esperto on the transaction. Esperto Medical™ (Esperto), a healthtech start-up specializing in critical care and remote patient monitoring, announced the...
SpectraWAVE’s $50 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised SpectraWAVE on the transaction. SpectraWAVE, Inc., a medical imaging company, has announced raising $50 million in Series B funding round...
Reunion Neuroscience’s $103 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, announced the close of a $103 million Series A...